However, advanced FIGO stage (stage III/IV versus stage I/II, HR: 3.14 (95% CI: 1.60-7.14), p = 0.01), lymph node metastasis (yes versus no, HR: 4.51 (95% CI: 1.21-16.83), p = 0.025), and an increased expression level of uPA (high versus low, HR: 3.38 (95% CI: 1.20-9.49), p = 0.021) had a significantly poor impact on the DFS in univariate analysis. The gene discussed is PLAU; the disease is metastatic malignant neoplasm in the lymph nodes.